Unimed Pharm passes U.S. FDA’s onsite inspection for disposable artificial tears
A eye drop company Unimed Pharm(CEO Gun-Nam Kim) announced on the 20th that they successfully passed the U.S. FDA onsite inspection recently for the disposable eye drop ‘Carboxymethylcellulose sodium 0.5%.’
The company said they have shipped a significant amount of the product since their first ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.